Overcoming Scale-Up Challenges in Viral Vector Production

As viral vector therapies advance toward late-stage development and commercialization, manufacturers must scale their production processes, including Tangential Flow Filtration (TFF), essential for concentration, washing, and buffer exchange, without compromising yield, compliance, or workflow continuity.

Download the White Paper

First Name *

Last Name *

Email *

Phone *

Country *

Company *

By checking this box, I consent to receive information from Enggmedia and its partners about their products and services. I understand that I can opt-out at any time. For more details on how we handle your personal data and your rights, please read our privacy policy.